Table 1 Anthropometric and metabolic data of 55 obese individuals at RYGB surgery
From: Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery
Variables | NGT (n = 19) | IGT (n = 9) | T2DM (n = 27) | rsNGT (n = 8) | rsT2DM (n = 8) |
|---|---|---|---|---|---|
Age | 44 ± 8 | 47 ± 10 | 54 ± 7* | 43 ± 9 | 50 ± 7 |
BMI (kg/m2) | 46 ± 6 | 49 ± 4 | 49 ± 10 | 44 ± 5 | 49 ± 10 |
HbA1c (%) | 5.5 ± 0.4 | 5.6 ± 0.5 | 7.6 ± 1.1* | 5.4 ± 0.2 | 7.1 ± 1 |
HOMA-IR | 3.7 ± 3.6 | 6.1 ± 3.1 | 10.8 ± 8.6* | 2.5 ± 0.5 | 10.3 ± 6.2 |
Fasting insulin (pmol/L) | 109 ± 96 | 164 ± 80 | 196 ± 115† | 80 ± 16 | 219 ± 127 |
Fasting glucose (mmol/L) | 5.1 ± 0.6 | 5.7 ± 0.57 | 8.1 ± 2.3* | 4.9 ± 0.4 | 7.4 ± 1.9 |
Gender | |||||
Female (%) | 16 (84) | 6 (66) | 15 (55) | 6 (75) | 5 (63) |
Male | 3 | 3 | 12 | 2 | 3 |
Diabetes | |||||
Previously unrecognized (%) | - | - | 7 (27) | - | 3 (37.5) |
Diet Controlled (%) | - | - | 2 (8) | - | 1 (12.5) |
Oral hypoglycaemics (%) | - | - | 14 (50) | - | 4 (50) |
Insulin taking (%) | - | - | 4 (15) | - | 0 |